Holen Sie sich die Stockscreener-App
0.89
6.92%
-0.0662
Schlusskurs vom Vortag:
$0.9562
Offen:
$0.96
24-Stunden-Volumen:
220.32K
Relative Volume:
0.82
Marktkapitalisierung:
$39.95M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-0.5329
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
-11.88%
1M Leistung:
-39.46%
6M Leistung:
-64.54%
1J Leistung:
-81.26%
1-Tages-Spanne:
$0.88
$1.05
1-Wochen-Bereich:
$0.88
$1.07
52-Wochen-Spanne:
$0.8645
$6.50
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.89 | 39.95M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.72 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.00 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
336.09 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.30 | 105.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.96 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN
TELA Bio to Announce First Quarter 2025 Financial Results | TELA Stock News - GuruFocus
TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewswire
TELA Bio, Inc. (NASDAQ:TELA) Stock Position Boosted by Commonwealth Equity Services LLC - Defense World
Prudential Financial Inc. Takes $57,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Tela Bio slumps after Q4 miss as Piper Sandler downgrades - MSN
TELA Bio Expands OviTex PRS Line with Larger Surgical Sizes - MSN
Canaccord maintains TELA Bio stock with $7 target post-challenges By Investing.com - Investing.com Canada
Canaccord maintains TELA Bio stock with $7 target post-challenges - Investing.com
Tela Bio stock plunges to 52-week low of $1.13 amid market challenges - Investing.com Canada
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 50% - simplywall.st
TELA Bio introduces larger sizes for soft tissue reconstruction - Investing.com India
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery - GlobeNewswire
Revolutionary Expansion: TELA Bio's New OviTex PRS Sizes Set Industry Record as Sales Surge 31% - Stock Titan
TELA Bio introduces larger sizes for soft tissue reconstruction By Investing.com - Investing.com UK
TELA Bio’s Earnings Call: Challenges and Optimism for 2025 - MSN
TELA Bio (NASDAQ:TELA) Cut to “Neutral” at Piper Sandler - The AM Reporter
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook - MSN
TELA Bio’s SWOT analysis: biologic platform maker faces growth hurdles By Investing.com - Investing.com Canada
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $7.00 - Defense World
TELA Bio (NASDAQ:TELA) Rating Lowered to “Neutral” at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA investor three-year losses grow to 88% as the stock sheds US$35m this past week - simplywall.st
TELA Bio Full Year 2024 Earnings: Revenues Disappoint - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call Transcript - Insider Monkey
Tela Bio downgraded to Neutral from Overweight at Piper Sandler - TipRanks
TELA Bio’s SWOT analysis: biologic platform maker faces growth hurdles - Investing.com India
TELA Bio stock price target cut to $7 by Citizens JMP - Investing.com Canada
TELA Bio Inc. (TELA) reports earnings - Quartz
TELA Bio, Inc. SEC 10-K Report - TradingView
Sector Update: Health Care - TradingView
TELA Bio stock plunges to 52-week low of $1.9 amid market challenges - Investing.com India
TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover - Yahoo
TELA Bio’s Hold Rating: Challenges in Sales Force Turnover and Financial Outlook - TipRanks
Tela Bio stock falls as Piper downgrades on Q4 miss (TELA) - Seeking Alpha
Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result - Yahoo Finance
TELA Bio stock plunges to 52-week low of $1.9 amid market challenges By Investing.com - Investing.com South Africa
Earnings call transcript: Tela Bio Q4 2024 misses earnings, stock drops By Investing.com - Investing.com Australia
Canaccord cuts TELA Bio stock target to $7, maintains Buy By Investing.com - Investing.com South Africa
Canaccord cuts TELA Bio stock target to $7, maintains Buy - Investing.com
Piper Sandler Downgrades TELA Bio to Neutral From Overweight, Adjusts Price Target to $2 From $5 - MarketScreener
Tela Bio earnings missed by $0.01, revenue fell short of estimates - Investing.com India
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):